OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Brody on Tolerability of In-Situ Vaccines in Indolent Non-Hodgkin Lymphoma

April 16th 2020

Joshua Brody, MD, discusses the utility of in-situ vaccines as a novel way to harness immune response and extend the reach of immunotherapy in patients with advanced-stage indolent non-Hodgkin lymphoma.

Dr. Cutler on Novel Preventive Strategies Against GVHD

April 16th 2020

Corey S. Cutler, MD, MPH, FRCPC, discusses some of the novel preventive strategies against graft-versus-host disease.

Dr. Rizvi on Brentuximab Vedotin Combinations in Hodgkin Lymphoma

April 16th 2020

Syed Rizvi, MD, discusses research efforts exploring brentuximab vedotin combinations in patients with Hodgkin lymphoma.

Dr. Joshi on Rationale for Durvalumab/RT Combo in Localized Urothelial Carcinoma

April 15th 2020

Monika Joshi, MD, discusses the rationale for using durvalumab in combination with radiation therapy in patients with localized urothelial carcinoma.

Dr. Fader on the Rationale for Targeting HER2/neu in Uterine Serous Carcinoma

April 15th 2020

Amanda Nickles Fader, MD, discusses the rationale for utilizing HER2/neu as a target in uterine serous carcinoma.

Dr. Shah on Optimal Sequencing in Gastroesophageal Cancer

April 15th 2020

Manish A. Shah, MD, discusses an optimal sequencing strategy in gastroesophageal cancer.

Dr. Halmos on Adapting Practice in Response to the COVID-19 Crisis

April 15th 2020

Balazs Halmos, MD, MS, provides insight into how his institution continues to adapt in response to the COVID-19 crisis.

Dr. Alshaygy on Precision Medicine Research in TGCT

April 15th 2020

Ibrahim S. Alshaygy, MD, MSC, discusses precision medicine research in tenosynovial giant cell tumor.

Dr. Morris on OS Data With Apalutamide in Prostate Cancer

April 15th 2020

David Morris, MD, FACS, discusses overall survival data with apalutamide in prostate cancer.

Dr. Dimou on Progress Made in ALK+ Lung Cancer Treatment

April 15th 2020

Anastasios (Tassos) Dimou, MD, discusses the progress made in the treatment of patients with ALK-positive lung cancer.

Dr. Kahl on Efficacy of Targeted Agents in Relapsed/Refractory Indolent Lymphomas

April 15th 2020

Brad Kahl, MD, discusses the efficacy of targeted agents across indolent lymphomas.

Dr. Goodman on the Need for Molecular Subtyping in T-Cell Lymphomas

April 15th 2020

Aaron Goodman, MD, discusses the need for molecular subtyping in T-cell lymphomas.

Dr. Janjigian on the JAVELIN Gastric 100 Study With Avelumab in Gastric/GEJ Cancer

April 14th 2020

Yelena Y. Janjigian, MD, discusses results from the phase III JAVELIN Gastric 100 study evaluating avelumab in gastric or gastroesophageal cancer.

Dr. O'Reilly on the Potential Role of Veliparib in Pancreatic Cancer

April 14th 2020

Eileen O'Reilly, MD, discusses the potential role of veliparib in pancreatic cancer.

Dr. Ilson on the Utility of Zolbetuximab in Claudin-Positive Gastric Cancers

April 14th 2020

David H. Ilson, MD, PhD, discusses the utility of zolbetuximab in claudin-positive gastric cancers.

Dr. Abdul-Hay on the Future of Targeted Therapy in ALL

April 14th 2020

Mohammad Maher Abdul-Hay, MD, discusses the future of targeted therapy in acute lymphoblastic leukemia.

Dr. Davies on the Use of Carfilzomib in Multiple Myeloma

April 14th 2020

Faith E. Davies, MD, discusses the dosing of carfilzomib in the treatment of patients with multiple myeloma.

Dr. Pemmaraju on the Need for Collaboration in Myelofibrosis

April 14th 2020

Naveen Pemmaraju, MD, discusses the need for collaboration when diagnosing and treating patients with myelofibrosis.

Dr. Jain on GVHD From Allogeneic Stem Cell Transplant

April 14th 2020

Tania Jain, MBBS, discusses the potential for graft-versus-host disease as a complication of allogeneic stem cell transplant.

Dr. Morgan on the Role of Venetoclax in Multiple Myeloma

April 14th 2020

Gareth J. Morgan, MD, PhD, discusses the role of venetoclax in treating patients with multiple myeloma.